{"schema_version":"secwatch.filing_event.v1","accession":"0001823239-25-000059","form_type":"8-K","ticker":"MRVI","cik":"0001823239","company_name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","filed_at":"2025-03-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.087839+00:00","generated_at":"2026-05-24T10:41:49.682479+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Maravai LifeSciences guides 2025 revenue $185M-$205M; Q1 revenue $43M-$45M","bullets":["Full-year 2025 revenue guidance $185M-$205M; Q1 2025 revenue $43M-$45M.","Adjusted EBITDA excludes interest ($14-16M), D&A ($50-55M), stock-based comp ($45-50M).","Fully diluted shares ~256M; capex expected $15M-$20M in 2025.","Guidance excludes impact of potential new acquisitions or unquantified items."],"urls":{"canonical":"https://secwatch.observer/filing/0001823239-25-000059","json":"https://secwatch.observer/filing/0001823239-25-000059.json","markdown":"https://secwatch.observer/filing/0001823239-25-000059.md","text":"https://secwatch.observer/filing/0001823239-25-000059.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1823239/000182323925000059/0001823239-25-000059-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1823239/000182323925000059/mrvi-20250320.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T10:41:49.682479+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}